<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020074"><a href="http://purl.obolibrary.org/obo/MONDO_0020074">MONDO:0020074</a></h3>
<p><strong>Label:</strong> progressive myoclonic epilepsy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009698">MONDO:0009698</a> (Unverricht-Lundborg syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0015674">MONDO:0015674</a> (late infantile neuronal ceroid lipofuscinosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019261">MONDO:0019261</a> (infantile neuronal ceroid lipofuscinosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019262">MONDO:0019262</a> (juvenile neuronal ceroid lipofuscinosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019260">MONDO:0019260</a> (adult neuronal ceroid lipofuscinosis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_600143">OMIM:600143</a>, <a href="http://www.orpha.net/ORDO/Orphanet_168491">Orphanet:168491</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601780">OMIM:601780</a>, <a href="http://purl.obolibrary.org/obo/OMIM_162350">OMIM:162350</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615362">OMIM:615362</a>, <a href="http://purl.obolibrary.org/obo/OMIM_310370">OMIM:310370</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256730">OMIM:256730</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256731">OMIM:256731</a>, <a href="http://purl.obolibrary.org/obo/OMIM_204200">OMIM:204200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_204300">OMIM:204300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_204500">OMIM:204500</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612437">OMIM:612437</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254800">OMIM:254800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79262">Orphanet:79262</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610951">OMIM:610951</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610127">OMIM:610127</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79263">Orphanet:79263</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79264">Orphanet:79264</a>, <a href="http://www.orpha.net/ORDO/Orphanet_308">Orphanet:308</a>, <a href="http://purl.obolibrary.org/obo/OMIM_214200">OMIM:214200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614706">OMIM:614706</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609055">OMIM:609055</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011813">HP:0011813</a> (Increased cerebral lipofuscin) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001250">HP:0001250</a> (Seizures) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011813">HP:0011813</a> (Increased cerebral lipofuscin) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001250">HP:0001250</a> (Seizures) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011813">HP:0011813</a> (Increased cerebral lipofuscin) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001250">HP:0001250</a> (Seizures) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011813">HP:0011813</a> (Increased cerebral lipofuscin) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001250">HP:0001250</a> (Seizures) and <a href="http://purl.obolibrary.org/obo/HP_0002074">HP:0002074</a> (Increased neuronal autofluorescent lipopigment) 70.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011813">HP:0011813</a> (Increased cerebral lipofuscin) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) 68.18%</li>
</ul>
</body>
</html>
